A Phase 1 Dose-escalation and Expansion Study of In Vivo BCMA-CAR T Cell Therapy (VV169) in Patients With Relapsed or Refractory Multiple Myeloma

计划入组 40 人 · 首次发布于 2026 年 9 月 3 日

Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers

计划入组 82 人 · 首次发布于 2023 年 10 月 27 日

Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults

计划入组 500 人 · 首次发布于 2026 年 7 月 15 日

Vyriad's VV169 In Vivo CAR-T Therapy Achieves 100% Tumor Clearance in Multiple Myeloma Preclinical Studies

Ori Biotech Signs 10-Year, $120M Deal to Move a Commercial Cell Therapy onto Its IRO Platform